p63 Immunohistochemistry Differentiates Salivary Gland Oncocytoma and Oncocytic Carcinoma from Metastatic Renal Cell Carcinoma

Head and Neck Pathology

Volumn 1, Issue 2, 2007, Pages 123-131

  McHugh, Jonathan B ^a   Hoschar, Aaron P ^b   Dvorakova, Mari ^c   Parwani, Anil V ^c   Barnes, E Leon ^c   Seethala, Raja R ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Metastatic renal cell carcinoma; Oncocytic carcinoma; Oncocytoma; p63

Indexed keywords

CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; METASTASIS; ONCOCYTOMA; PREDICTION AND FORECASTING; SALIVARY GLAND TUMOR;

ADENOCARCINOMA, CLEAR CELL; ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KIDNEY NEOPLASMS; MEMBRANE PROTEINS; PREDICTIVE VALUE OF TESTS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 48349109973     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-007-0031-4     Document Type: Article

References (36)

1. Tandler B, Hutter RV, Erlandson RA. Ultrastructure of oncocytoma of the parotid gland. Lab Invest 1970;23:567-80
2. Palmer TJ, Gleeson MJ, Eveson JW, et al. Oncocytic adenomas and oncocytic hyperplasia of salivary glands: a clinicopathological study of 26 cases. Histopathology 1990;16:487-93
3. Ellis G, Auclair P. Atlas of tumor pathology. Tumors of the salivary glands. 3rd ed. Washington DC: Armed Forces Institute of Pathology; 1996
4. Brandwein MS, Huvos AG. Oncocytic tumors of major salivary glands. A study of 68 cases with follow-up of 44 patients. Am J Surg Pathol 1991;15:514-28
5. Ellis GL. "Clear cell" oncocytoma of salivary gland. Hum Pathol 1988;19:862-7
6. Wang B, Brandwein M, Gordon R, et al. Primary salivary clear cell tumors-a diagnostic approach: a clinicopathologic and immunohistochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelialmyoepithelial carcinoma. Arch Pathol Lab Med 2002;126:676-85
7. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol 2007;31:44-57
8. Maiorano E, Altini M, Favia G. Clear cell tumors of the salivary glands, jaws, and oral mucosa. Semin 1997;14:203-12
9. Ozolek JA, Bastacky SI, Myers EN, et al. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma. Laryngoscope 2005;115:1097-100
10. Ellis G, Auclair P, Gnepp D, et al. Surgical pathology of the salivary glands. Philadelphia: W.B. Sanders; 1991
11. Capone RB, Ha PK, Westra WH, et al. Oncocytic neoplasms of the parotid gland: a 16-year institutional review. Otolaryngol Head Neck Surg 2002;126:657-62
12. Chang A, Harawi SJ. Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu 1992;27 Pt 1:263-304
13. Goode RK, Corio RL. Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol 1988;65:61-6
14. Nakada M, Nishizaki K, Akagi H, et al. Oncocytic carcinoma of the submandibular gland: a case report and literature review. J Oral Pathol Med 1998;27:225-8
15. Boles R, Cerny J. Head and neck metastases from renal carcinomas. Mich Med 1971;70:616-8
16. Pritchyk KM, Schiff BA, Newkirk KA, et al. Metastatic renal cell carcinoma to the head and neck. Laryngoscope 2002;112: 1598-602
17. Cheng ET, Greene D, Koch RJ. Metastatic renal cell carcinoma to the nose. Otolaryngol Head Neck Surg 2000;122:464
18. Miyamoto R, Helmus C. Hypernephroma metastatic to the head and neck. Laryngoscope 1973;83:898-905
19. Owens RM, Friedman CD, Becker SP. Renal cell carcinoma with metastasis to the parotid gland: case reports and review of the literature. Head Neck 1989;11:174-8
20. Rees R, Maples M, Lynch JB, et al. Malignant secondary parotid tumors. South Med J 1981;74:1050-2
21. Yarington Jr CT. Metastatic malignant disease to the parotid gland. Laryngoscope 1981;91:517-9
22. Seifert G, Hennings K, Caselitz J. Metastatic tumors to the parotid and submandibular glands-analysis and differential diagnosis of 108 cases. Pathol Res Pract 1986;181:684-92
23. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-16
24. Parsa R, Yang A, McKeon F, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113:1099-1105
25. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-8
26. Barbareschi M, Pecciarini L, Cangi MG. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-60
27. Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280-9
28. Yang A, Kaghad M, Caput D, et al. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90-5
29. Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 2002;441:428-36
30. Bilal H, Handra-Luca A, Bertrand J-C, et al. p63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51:133-9
31. Foschini MP, Gaiba A, Cocchi R, et al. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Int J Surg Pathol 2005;13:329-5
32. Seethala RR, LiVolsi VA, Zhang PJ, et al. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 2005;27:696-702
33. Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78:2281-7
34. Langner C, Ratschek M, Tsybrovskyy O, et al. p63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003;51:1097-9
35. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501
36. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001;116:823-30